Amphetamine is a controlled drug in Australia: import requires a prior import permit issued by OICS (Standing/Individual Import Authority) and must meet the licensing conditions of the Customs (Prohibited Imports) Regulations; import without a permit does not attract the personal-use exemption and is a prosecutable matter. The ABF medicines-carry page lists such controlled drugs as requiring declaration and requiring permit or prescription support.
AU-STIMULANT-01Prior permit requiredVerified against source · 2026-11-03Amphetamine is a controlled drug in Australia: import requires a prior import permit issued by OICS (Standing/Individual Import Authority) and must meet the licensing conditions of the Customs (Prohibited Imports) Regulations; import without a permit does not attract the personal-use exemption and is a prosecutable matter. The ABF medicines-carry page lists such controlled drugs as requiring declaration and requiring permit or prescription support.
※ To verify: the au-oics-scheduled-drugs page could not be opened this round; the permit-requirement conclusion was obtained by cross-verification between the ABF medicines page and the TGA personal-import page; the penalty amount remains a data debt.
AU-CONTROLLED-01Prior permit requiredVerified against source · 2026-11-03Entering Australia with controlled-drug ingredients (opioids Schedule 8, certain CBD preparations, ephedrine-class precursors, prescription peptides) requires prior permission: Customs (Prohibited Imports) Regulations demand an OICS import permit, and TGA separately requires prescription or registration support. Import without a permit does not attract the personal-use exemption.
※ This rule completes the three-country symmetry with NZ-CONTROLLED-01 / JP-CONTROLLED-01. ★ Pre-fix gap: ephedra / BPC-157 / CBD cartridges / oxycodone previously hit only AU-HERBAL-01 (conditional) in AU — too permissive; they are now unified onto the controlled path requiring prior permission. To verify: Schedule classification details and CBD (Schedule 3 prescription vs illicit industrial hemp products) were not read from source item by item this round, so the most conservative line is applied. Known parallel: with AU-STIMULANT-01 both are permit_required for adderall, which triggers the equal-strictness data QA note — an intentional layering overlap (same as JP-MEAT-01 with JP-ANIMALPROD-ATTR-01).
AU-HERBAL-01ConditionalVerified against source · 2026-11-03Supplements with medicinal / botanical-active claims fall under TGA jurisdiction in Australia. Unapproved therapeutic goods may be imported personally via the Personal Importation Scheme; TGA's wording is: no more than a 3-month supply per order, no more than 15 months' supply cumulative over 12 months, for personal use only and must not be resold; prescription-class ingredients need prescription support, and over-quantity amounts require a Special Access application by an Australian-registered medical practitioner.
※ Cross-verified between the TGA page (2026-09-08 version) and the ABF medicines-carry page; the 15-month annual cap is a TGA original figure and must be re-read at next review.
Amphetamine is a controlled drug in Australia: import requires a prior import permit issued by OICS (Standing/Individual Import Authority) and must meet the licensing conditions of the Customs (Prohibited Imports) Regulations; import without a permit does not attract the personal-use exemption and is a prosecutable matter. The ABF medicines-carry page lists such controlled drugs as requiring declaration and requiring permit or prescription support.
AU-STIMULANT-01Prior permit requiredVerified against source · 2026-11-03Amphetamine is a controlled drug in Australia: import requires a prior import permit issued by OICS (Standing/Individual Import Authority) and must meet the licensing conditions of the Customs (Prohibited Imports) Regulations; import without a permit does not attract the personal-use exemption and is a prosecutable matter. The ABF medicines-carry page lists such controlled drugs as requiring declaration and requiring permit or prescription support.
※ To verify: the au-oics-scheduled-drugs page could not be opened this round; the permit-requirement conclusion was obtained by cross-verification between the ABF medicines page and the TGA personal-import page; the penalty amount remains a data debt.
AU-CONTROLLED-01Prior permit requiredVerified against source · 2026-11-03Entering Australia with controlled-drug ingredients (opioids Schedule 8, certain CBD preparations, ephedrine-class precursors, prescription peptides) requires prior permission: Customs (Prohibited Imports) Regulations demand an OICS import permit, and TGA separately requires prescription or registration support. Import without a permit does not attract the personal-use exemption.
※ This rule completes the three-country symmetry with NZ-CONTROLLED-01 / JP-CONTROLLED-01. ★ Pre-fix gap: ephedra / BPC-157 / CBD cartridges / oxycodone previously hit only AU-HERBAL-01 (conditional) in AU — too permissive; they are now unified onto the controlled path requiring prior permission. To verify: Schedule classification details and CBD (Schedule 3 prescription vs illicit industrial hemp products) were not read from source item by item this round, so the most conservative line is applied. Known parallel: with AU-STIMULANT-01 both are permit_required for adderall, which triggers the equal-strictness data QA note — an intentional layering overlap (same as JP-MEAT-01 with JP-ANIMALPROD-ATTR-01).
AU-HERBAL-01ConditionalVerified against source · 2026-11-03Supplements with medicinal / botanical-active claims fall under TGA jurisdiction in Australia. Unapproved therapeutic goods may be imported personally via the Personal Importation Scheme; TGA's wording is: no more than a 3-month supply per order, no more than 15 months' supply cumulative over 12 months, for personal use only and must not be resold; prescription-class ingredients need prescription support, and over-quantity amounts require a Special Access application by an Australian-registered medical practitioner.
※ Cross-verified between the TGA page (2026-09-08 version) and the ABF medicines-carry page; the 15-month annual cap is a TGA original figure and must be re-read at next review.
Most permits take weeks to process and must be applied for in advance. The ones you remember the day before departure are usually too late.
| Carrier | Stance | Notes |
|---|---|---|
| USPS | ⛔ Refused | — Note: this answer says nothing about Australia import law and is not grounds for release. |
A call center only says “we don’t take it”. Every path below is a concrete change that turns “no” into “yes, if you do this”. The badge beside each path is recomputed by running the modified item through the rule engine — trust that, not the promise.
Additional documents: OICS Standing / Individual Import Authority; Original English prescription
Amounts follow the current publication of Australia regulators; we never show unverified numbers on a page. Decision-grade ranges appear in the “penalty exposure” section of the full dossier.
One call answers “do you take it” but never “does the country allow it”. Only after all four questions do you have the complete answer. Note the agent's ID and the time of each answer.
“I want to send Amphetamine / dextroamphetamine salts (Adderall) (standard retail packaging) from [origin country] to Australia via postal parcel. Does your network accept it?”
Why ask it this way: Ask acceptance first, never compliance — agents are responsible for what they carry, and a compliance question only earns a disclaimer.
“If you accept it: exactly how must the waybill describe the contents? What labels or enclosed documents do you require? Please give me the specific wording.”
Why ask it this way: A waybill description that mismatches the contents is the number-one trigger for inspection. You need exact wording, not “be more detailed”.
“If you don't: which prohibited-items clause applies? Would a change in [processing / packaging / quantity] make it acceptable? Do any of your other services carry it?”
Why ask it this way: Turn “no” into “yes, under condition X” — this question routinely surfaces routes the carrier would never volunteer.
“Is your refusal based on Australia import restrictions, or on your own policy? Can you give me the written link or clause number?”
Why ask it this way: This separates the two switches. Carrier policy can be switched; import law cannot — the answer decides your next move.
DECLARATION — 申告 / 申报
I am carrying/mailing the following item for personal use. / 私は個人使用のために以下の物品を持ち込みます（発送します）。
Item / 物品 : Amphetamine / dextroamphetamine salts (Adderall)
Nature / 性質 : synthetic · medicine · concentrate
Quantity / 数量 : 1 month supply
Channel : postal parcel
Documents held / 保有書類:
— OICS Import Authority (lead time is counted in weeks; cannot be resolved just before travel)
— Original English prescription
— Original packaging with ingredient label
— OICS Import Authority
— English prescription / doctor's letter
— Ingredient and dosage label
Generated by this site on 2026-11-10. Informational aid only — not an official document, permit, or guarantee of admission. 本卡片为信息辅助文件，非官方文件、非许可、不保证放行。
⚠️ Print this page alone. The card is designed to be shown by itself — the officer does not need our verdicts or sources.
Links go to the regulator's or carrier's own pages. We do not host, mirror, or replace the source text. If you believe a verdict here conflicts with the official wording, tell us and include the link — confirmed errors are corrected publicly.
A carrier answers “do we take this on our network today”; import and biosecurity authorities in Australia answers “does this country let it in”. Two independent questions — no single institution answers both, and seized parcels almost always trace back to asking only one. This site solves the two switches together and shows you what change makes it work.
Selling (Shopify / Etsy / your own store)? One-off verdicts don't scale — see the For sellers: bulk SKU checking and rule-change alerts ($29/month).